Profile | GDS4284 / 209780_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 12992.6 | 98 |
GSM687648 | Patient 402 control | 16880.4 | 99 |
GSM687653 | Patient 403 control | 19610.3 | 99 |
GSM687658 | Patient 404 control | 9676.76 | 97 |
GSM687663 | Patient 411 control | 11372.1 | 97 |
GSM687668 | Patient 422 control | 11192.7 | 97 |
GSM687673 | Patient 424 control | 11089 | 97 |
GSM687678 | Patient 425 control | 7214.91 | 96 |
GSM687683 | Patient 427 control | 8294.39 | 96 |
GSM687688 | Patient 428 control | 10543.7 | 97 |
GSM687695 | Patient 441 control | 2972.01 | 90 |
GSM687699 | Patient 443 control | 5882.36 | 95 |
GSM687704 | Patient 444 control | 12505.5 | 98 |
GSM687707 | Patient 448 control | 16377.4 | 98 |
GSM687712 | Patient 449 control | 15712.7 | 98 |
GSM687719 | Patient 450 control | 9792.36 | 97 |
GSM687724 | Patient 451 control | 16940.5 | 98 |
GSM687728 | Patient 452 control | 11882 | 98 |
GSM687646 | Patient 401 treated 24h | 14305.4 | 98 |
GSM687649 | Patient 402 treated 24h | 17213.3 | 99 |
GSM687665 | Patient 411 treated 24h | 13218.6 | 98 |
GSM687651 | Patient 402 treated 4 weeks | 13471.7 | 98 |
GSM687667 | Patient 411 treated 4 weeks | 16474.3 | 99 |
GSM687670 | Patient 422 treated 24h | 10413.4 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 11417.9 | 98 |
GSM687654 | Patient 403 treated 24h | 17622.5 | 98 |
GSM687675 | Patient 424 treated 24h | 11946.3 | 98 |
GSM687685 | Patient 427 treated 24h | 7462.3 | 96 |
GSM687656 | Patient 403 treated 4 weeks | 16110.3 | 98 |
GSM687677 | Patient 424 treated 4 weeks | 9616.35 | 97 |
GSM687687 | Patient 427 treated 4 weeks | 10902.1 | 97 |
GSM687692 | Patient 428 treated 4h | 14605.4 | 98 |
GSM687716 | Patient 449 treated 4h | 15264.9 | 98 |
GSM687722 | Patient 450 treated 4h | 10609.6 | 97 |
GSM687680 | Patient 425 treated 24h | 9254.97 | 97 |
GSM687690 | Patient 428 treated 24h | 15684.9 | 98 |
GSM687700 | Patient 443 treated 24h | 4716.09 | 93 |
GSM687705 | Patient 444 treated 24h | 7862.95 | 96 |
GSM687714 | Patient 449 treated 24h | 15194.2 | 98 |
GSM687721 | Patient 450 treated 24h | 7301.43 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 7754 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 12135.1 | 98 |
GSM687702 | Patient 443 treated 4 weeks | 7923.73 | 96 |
GSM687718 | Patient 449 treated 4 weeks | 14302.3 | 98 |
GSM687723 | Patient 450 treated 4 weeks | 11234.3 | 97 |
GSM687661 | Patient 404 treated 4h | 9352.98 | 97 |
GSM687710 | Patient 448 treated 4h | 15948.5 | 98 |
GSM687726 | Patient 451 treated 4h | 14627.9 | 98 |
GSM687730 | Patient 452 treated 4h | 6246.61 | 95 |
GSM687660 | Patient 404 treated 24h | 5582.77 | 94 |
GSM687697 | Patient 441 treated 24h | 3952.67 | 92 |
GSM687709 | Patient 448 treated 24h | 16341.3 | 98 |
GSM687725 | Patient 451 treated 24h | 11732 | 98 |
GSM687729 | Patient 452 treated 24h | 5404.53 | 94 |
GSM687727 | Patient 451 treated 4 weeks | 9574.62 | 97 |
GSM687731 | Patient 452 treated 4 weeks | 8020.23 | 96 |